APO Research

APO RESEARCH · REPORT

Cinnarizine Tablets

Selected research

Market Structure

Global Cinnarizine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Cinnarizine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cinnarizine Tablets include Actavis, Bristol Myers Squibb, Glenmark Pharmaceuticals, Johnson & Johnson, McNeil Products, Peak Pharmacy, Sanofi, Teva Pharmaceuticals and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cinnarizine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cinnarizine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cinnarizine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cinnarizine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Cinnarizine Tablets Segment by Company

Actavis

Bristol Myers Squibb

Glenmark Pharmaceuticals

Johnson & Johnson

McNeil Products

Peak Pharmacy

Sanofi

Teva Pharmaceuticals

Torrent Pharmaceuticals

Beijing Neptunus Zhongxin Pharmaceutical

Cisen Pharma

Harbin Pharmaceutical Group

Nanjing Baijingyu Pharmaceutical

Shanghai Xinyi Wanxiang Pharmaceutical

CSPC

Cinnarizine Tablets Segment by Type

15mg per Tablet

25mg per Tablet

Cinnarizine Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Cinnarizine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cinnarizine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cinnarizine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cinnarizine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cinnarizine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cinnarizine Tablets Industry Trends Table 2. Cinnarizine Tablets Industry Drivers Table 3. Cinnarizine Tablets Industry Opportunities and Challenges Table 4. Cinnarizine Tablets Industry Restraints Table 5. Global Cinnarizine Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cinnarizine Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cinnarizine Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cinnarizine Tablets Sales Market Share by Manufacturers Table 9. Global Cinnarizine Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cinnarizine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cinnarizine Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cinnarizine Tablets Manufacturers, Product Type & Application Table 13. Global Cinnarizine Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cinnarizine Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 15mg per Tablet Table 17. Major Manufacturers of 25mg per Tablet Table 18. Global Cinnarizine Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cinnarizine Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Cinnarizine Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Cinnarizine Tablets Sales Market Share by Type (2021-2026) Table 22. Global Cinnarizine Tablets Sales Market Share by Type (2027-2032) Table 23. Global Cinnarizine Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cinnarizine Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Cinnarizine Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Cinnarizine Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Cinnarizine Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Other Table 31. Global Cinnarizine Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cinnarizine Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Cinnarizine Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Cinnarizine Tablets Sales Market Share by Application (2021-2026) Table 35. Global Cinnarizine Tablets Sales Market Share by Application (2027-2032) Table 36. Global Cinnarizine Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cinnarizine Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Cinnarizine Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Cinnarizine Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Cinnarizine Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Cinnarizine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cinnarizine Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Cinnarizine Tablets Sales Market Share by Region (2021-2026) Table 44. Global Cinnarizine Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cinnarizine Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cinnarizine Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Cinnarizine Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cinnarizine Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Cinnarizine Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cinnarizine Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cinnarizine Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cinnarizine Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cinnarizine Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Cinnarizine Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cinnarizine Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cinnarizine Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cinnarizine Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Cinnarizine Tablets Revenue Market Share by Region (2027-2032) Table 63. Actavis Company Information Table 64. Actavis Business Overview Table 65. Actavis Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Actavis Cinnarizine Tablets Product Portfolio Table 67. Actavis Recent Development Table 68. Bristol Myers Squibb Company Information Table 69. Bristol Myers Squibb Business Overview Table 70. Bristol Myers Squibb Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bristol Myers Squibb Cinnarizine Tablets Product Portfolio Table 72. Bristol Myers Squibb Recent Development Table 73. Glenmark Pharmaceuticals Company Information Table 74. Glenmark Pharmaceuticals Business Overview Table 75. Glenmark Pharmaceuticals Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Glenmark Pharmaceuticals Cinnarizine Tablets Product Portfolio Table 77. Glenmark Pharmaceuticals Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Cinnarizine Tablets Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. McNeil Products Company Information Table 84. McNeil Products Business Overview Table 85. McNeil Products Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. McNeil Products Cinnarizine Tablets Product Portfolio Table 87. McNeil Products Recent Development Table 88. Peak Pharmacy Company Information Table 89. Peak Pharmacy Business Overview Table 90. Peak Pharmacy Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Peak Pharmacy Cinnarizine Tablets Product Portfolio Table 92. Peak Pharmacy Recent Development Table 93. Sanofi Company Information Table 94. Sanofi Business Overview Table 95. Sanofi Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sanofi Cinnarizine Tablets Product Portfolio Table 97. Sanofi Recent Development Table 98. Teva Pharmaceuticals Company Information Table 99. Teva Pharmaceuticals Business Overview Table 100. Teva Pharmaceuticals Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Teva Pharmaceuticals Cinnarizine Tablets Product Portfolio Table 102. Teva Pharmaceuticals Recent Development Table 103. Torrent Pharmaceuticals Company Information Table 104. Torrent Pharmaceuticals Business Overview Table 105. Torrent Pharmaceuticals Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Torrent Pharmaceuticals Cinnarizine Tablets Product Portfolio Table 107. Torrent Pharmaceuticals Recent Development Table 108. Beijing Neptunus Zhongxin Pharmaceutical Company Information Table 109. Beijing Neptunus Zhongxin Pharmaceutical Business Overview Table 110. Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Product Portfolio Table 112. Beijing Neptunus Zhongxin Pharmaceutical Recent Development Table 113. Cisen Pharma Company Information Table 114. Cisen Pharma Business Overview Table 115. Cisen Pharma Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Cisen Pharma Cinnarizine Tablets Product Portfolio Table 117. Cisen Pharma Recent Development Table 118. Harbin Pharmaceutical Group Company Information Table 119. Harbin Pharmaceutical Group Business Overview Table 120. Harbin Pharmaceutical Group Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Harbin Pharmaceutical Group Cinnarizine Tablets Product Portfolio Table 122. Harbin Pharmaceutical Group Recent Development Table 123. Nanjing Baijingyu Pharmaceutical Company Information Table 124. Nanjing Baijingyu Pharmaceutical Business Overview Table 125. Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Product Portfolio Table 127. Nanjing Baijingyu Pharmaceutical Recent Development Table 128. Shanghai Xinyi Wanxiang Pharmaceutical Company Information Table 129. Shanghai Xinyi Wanxiang Pharmaceutical Business Overview Table 130. Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Product Portfolio Table 132. Shanghai Xinyi Wanxiang Pharmaceutical Recent Development Table 133. CSPC Company Information Table 134. CSPC Business Overview Table 135. CSPC Cinnarizine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. CSPC Cinnarizine Tablets Product Portfolio Table 137. CSPC Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Cinnarizine Tablets Distributors List Table 141. Cinnarizine Tablets Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Cinnarizine Tablets Product Image Figure 2. Global Cinnarizine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cinnarizine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Cinnarizine Tablets Sales (2021-2032) & (K Units) Figure 5. Global Cinnarizine Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cinnarizine Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 15mg per Tablet Image Figure 9. 25mg per Tablet Image Figure 10. Global Cinnarizine Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cinnarizine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cinnarizine Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Cinnarizine Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cinnarizine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cinnarizine Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Retail Pharmacies Image Figure 18. Other Image Figure 19. Global Cinnarizine Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cinnarizine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cinnarizine Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Cinnarizine Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cinnarizine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cinnarizine Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cinnarizine Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cinnarizine Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cinnarizine Tablets Sales Market Share by Country (2021-2032) Figure 39. China Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cinnarizine Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cinnarizine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cinnarizine Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cinnarizine Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cinnarizine Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cinnarizine Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cinnarizine Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cinnarizine Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cinnarizine Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cinnarizine Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg per Tablet
  • 25mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Actavis
  • Bristol Myers Squibb
  • Glenmark Pharmaceuticals
  • Johnson & Johnson
  • McNeil Products
  • Peak Pharmacy
  • Sanofi
  • Teva Pharmaceuticals
  • Torrent Pharmaceuticals
  • Beijing Neptunus Zhongxin Pharmaceutical
  • Cisen Pharma
  • Harbin Pharmaceutical Group
  • Nanjing Baijingyu Pharmaceutical
  • Shanghai Xinyi Wanxiang Pharmaceutical
  • CSPC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cinnarizine Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cinnarizine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cinnarizine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cinnarizine Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cinnarizine Tablets Market Dynamics
  1. 2.1 Cinnarizine Tablets Industry Trends
  2. 2.2 Cinnarizine Tablets Industry Drivers
  3. 2.3 Cinnarizine Tablets Industry Opportunities and Challenges
  4. 2.4 Cinnarizine Tablets Industry Restraints
3 Cinnarizine Tablets Market by Manufacturers
  1. 3.1 Global Cinnarizine Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cinnarizine Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cinnarizine Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cinnarizine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cinnarizine Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cinnarizine Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Cinnarizine Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cinnarizine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cinnarizine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cinnarizine Tablets Tier 1, Tier 2, and Tier 3
4 Cinnarizine Tablets Market by Type
  1. 4.1 Cinnarizine Tablets Type Introduction
  2. 4.1.1 15mg per Tablet
  3. 4.1.2 25mg per Tablet
  4. 4.2 Global Cinnarizine Tablets Sales by Type
  5. 4.2.1 Global Cinnarizine Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cinnarizine Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Cinnarizine Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cinnarizine Tablets Revenue by Type
  9. 4.3.1 Global Cinnarizine Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cinnarizine Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Cinnarizine Tablets Revenue Market Share by Type (2021-2032)
5 Cinnarizine Tablets Market by Application
  1. 5.1 Cinnarizine Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Cinnarizine Tablets Sales by Application
  6. 5.2.1 Global Cinnarizine Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cinnarizine Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Cinnarizine Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cinnarizine Tablets Revenue by Application
  10. 5.3.1 Global Cinnarizine Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cinnarizine Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Cinnarizine Tablets Revenue Market Share by Application (2021-2032)
6 Global Cinnarizine Tablets Sales by Region
  1. 6.1 Global Cinnarizine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cinnarizine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Cinnarizine Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Cinnarizine Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cinnarizine Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cinnarizine Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cinnarizine Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cinnarizine Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cinnarizine Tablets Revenue by Region
  1. 7.1 Global Cinnarizine Tablets Revenue by Region
  2. 7.1.1 Global Cinnarizine Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cinnarizine Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Cinnarizine Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Cinnarizine Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cinnarizine Tablets Revenue (2021-2032)
  8. 7.2.2 North America Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cinnarizine Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cinnarizine Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cinnarizine Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis
  2. 8.1.1 Actavis Company Information
  3. 8.1.2 Actavis Business Overview
  4. 8.1.3 Actavis Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Cinnarizine Tablets Product Portfolio
  6. 8.1.5 Actavis Recent Developments
  7. 8.2 Bristol Myers Squibb
  8. 8.2.1 Bristol Myers Squibb Company Information
  9. 8.2.2 Bristol Myers Squibb Business Overview
  10. 8.2.3 Bristol Myers Squibb Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol Myers Squibb Cinnarizine Tablets Product Portfolio
  12. 8.2.5 Bristol Myers Squibb Recent Developments
  13. 8.3 Glenmark Pharmaceuticals
  14. 8.3.1 Glenmark Pharmaceuticals Company Information
  15. 8.3.2 Glenmark Pharmaceuticals Business Overview
  16. 8.3.3 Glenmark Pharmaceuticals Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glenmark Pharmaceuticals Cinnarizine Tablets Product Portfolio
  18. 8.3.5 Glenmark Pharmaceuticals Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Cinnarizine Tablets Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 McNeil Products
  26. 8.5.1 McNeil Products Company Information
  27. 8.5.2 McNeil Products Business Overview
  28. 8.5.3 McNeil Products Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 McNeil Products Cinnarizine Tablets Product Portfolio
  30. 8.5.5 McNeil Products Recent Developments
  31. 8.6 Peak Pharmacy
  32. 8.6.1 Peak Pharmacy Company Information
  33. 8.6.2 Peak Pharmacy Business Overview
  34. 8.6.3 Peak Pharmacy Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Peak Pharmacy Cinnarizine Tablets Product Portfolio
  36. 8.6.5 Peak Pharmacy Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Cinnarizine Tablets Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Cinnarizine Tablets Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Torrent Pharmaceuticals
  50. 8.9.1 Torrent Pharmaceuticals Company Information
  51. 8.9.2 Torrent Pharmaceuticals Business Overview
  52. 8.9.3 Torrent Pharmaceuticals Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Torrent Pharmaceuticals Cinnarizine Tablets Product Portfolio
  54. 8.9.5 Torrent Pharmaceuticals Recent Developments
  55. 8.10 Beijing Neptunus Zhongxin Pharmaceutical
  56. 8.10.1 Beijing Neptunus Zhongxin Pharmaceutical Company Information
  57. 8.10.2 Beijing Neptunus Zhongxin Pharmaceutical Business Overview
  58. 8.10.3 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Product Portfolio
  60. 8.10.5 Beijing Neptunus Zhongxin Pharmaceutical Recent Developments
  61. 8.11 Cisen Pharma
  62. 8.11.1 Cisen Pharma Company Information
  63. 8.11.2 Cisen Pharma Business Overview
  64. 8.11.3 Cisen Pharma Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cisen Pharma Cinnarizine Tablets Product Portfolio
  66. 8.11.5 Cisen Pharma Recent Developments
  67. 8.12 Harbin Pharmaceutical Group
  68. 8.12.1 Harbin Pharmaceutical Group Company Information
  69. 8.12.2 Harbin Pharmaceutical Group Business Overview
  70. 8.12.3 Harbin Pharmaceutical Group Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Harbin Pharmaceutical Group Cinnarizine Tablets Product Portfolio
  72. 8.12.5 Harbin Pharmaceutical Group Recent Developments
  73. 8.13 Nanjing Baijingyu Pharmaceutical
  74. 8.13.1 Nanjing Baijingyu Pharmaceutical Company Information
  75. 8.13.2 Nanjing Baijingyu Pharmaceutical Business Overview
  76. 8.13.3 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Product Portfolio
  78. 8.13.5 Nanjing Baijingyu Pharmaceutical Recent Developments
  79. 8.14 Shanghai Xinyi Wanxiang Pharmaceutical
  80. 8.14.1 Shanghai Xinyi Wanxiang Pharmaceutical Company Information
  81. 8.14.2 Shanghai Xinyi Wanxiang Pharmaceutical Business Overview
  82. 8.14.3 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Product Portfolio
  84. 8.14.5 Shanghai Xinyi Wanxiang Pharmaceutical Recent Developments
  85. 8.15 CSPC
  86. 8.15.1 CSPC Company Information
  87. 8.15.2 CSPC Business Overview
  88. 8.15.3 CSPC Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CSPC Cinnarizine Tablets Product Portfolio
  90. 8.15.5 CSPC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cinnarizine Tablets Value Chain Analysis
  2. 9.1.1 Cinnarizine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cinnarizine Tablets Production Mode & Process
  6. 9.2 Cinnarizine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cinnarizine Tablets Distributors
  9. 9.2.3 Cinnarizine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research